JUNS
Jupiter Neurosciences, Inc. Common Stock
NASDAQ: JUNS · HEALTHCARE · BIOTECHNOLOGY
$0.38
+5.33% today
Updated 2026-04-30
Market cap
$13.16M
P/E ratio
—
P/S ratio
603.58x
EPS (TTM)
$-0.25
Dividend yield
—
52W range
$0 – $3
Volume
0.1M
Jupiter Neurosciences, Inc. Common Stock (JUNS) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-142952.00 | $-254783.00 | $-1.74M | $-1.25M | $-480953.00 | $-3.91M | $-5.41M |
| Capital expenditures | $0.00 | $0.00 | $4.00 | $4.00 | $3.00 | $4.00 | $4.00 |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | $944577.00 | $563530.00 | $1.30M | $817251.00 | $1.20M | $1.84M | $2.42M |
| Free cash flow | $-142952.00 | $-254783.00 | $-1.74M | $-1.25M | $-480956.00 | $-3.91M | $-5.41M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — |